Cargando…
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
AIMS/HYPOTHESES: We aimed to quantify the association of individual circulating amino acids with macrovascular disease, microvascular disease and all-cause mortality in individuals with type 2 diabetes. METHODS: We performed a case-cohort study (N = 3587), including 655 macrovascular events, 342 mic...
Autores principales: | Welsh, Paul, Rankin, Naomi, Li, Qiang, Mark, Patrick B., Würtz, Peter, Ala-Korpela, Mika, Marre, Michel, Poulter, Neil, Hamet, Pavel, Chalmers, John, Woodward, Mark, Sattar, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445481/ https://www.ncbi.nlm.nih.gov/pubmed/29728717 http://dx.doi.org/10.1007/s00125-018-4619-x |
Ejemplares similares
-
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017) -
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
por: Harris, Katie, et al.
Publicado: (2020) -
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009) -
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016) -
Endothelium in Coronary Macrovascular and Microvascular Diseases
por: Godo, Shigeo, et al.
Publicado: (2021)